AIMS: The blood tests used traditionally as markers of excessive drinking are the liver enzymes, gamma glutamyltransferase (GGT), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and the red blood cell volume (mean corpuscular volume: MCV). Here we review the nature of these markers' association with alcohol use, their practical application in detecting, assessing or monitoring drinking and increases in understanding of these markers in the past 10 years. DESIGN: Articles were identified via Medline search and perusal of bibliographies. FINDINGS: The conventional markers have imperfect sensitivity and specificity, but have an added clinical role in the detection of complications of drinking, and of comorbid conditions that may increase risk of drinking. GGT may in part be a marker of the oxidative stress associated with ethanol metabolism. Markers are more likely to be elevated in those aged more than 30 years and in regular drinkers with a longer drinking history. The markers may be useful in opportunistic case finding, in motivating patients to change drinking and in monitoring treatment response. Increased prevalence of obesity and hepatitis C must be considered in interpretation of liver enzyme results. The liver enzymes are prognostic indicators for several medical conditions and for mortality. CONCLUSIONS: These conventional tests are widely available and relatively inexpensive. While having limited sensitivity and specificity in detection of excessive drinking, they also provide valuable data on complications of drinking, comorbid conditions that may be affected by drinking and, in some cases, prognosis.
AIMS: The blood tests used traditionally as markers of excessive drinking are the liver enzymes, gamma glutamyltransferase (GGT), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and the red blood cell volume (mean corpuscular volume: MCV). Here we review the nature of these markers' association with alcohol use, their practical application in detecting, assessing or monitoring drinking and increases in understanding of these markers in the past 10 years. DESIGN: Articles were identified via Medline search and perusal of bibliographies. FINDINGS: The conventional markers have imperfect sensitivity and specificity, but have an added clinical role in the detection of complications of drinking, and of comorbid conditions that may increase risk of drinking. GGT may in part be a marker of the oxidative stress associated with ethanol metabolism. Markers are more likely to be elevated in those aged more than 30 years and in regular drinkers with a longer drinking history. The markers may be useful in opportunistic case finding, in motivating patients to change drinking and in monitoring treatment response. Increased prevalence of obesity and hepatitis C must be considered in interpretation of liver enzyme results. The liver enzymes are prognostic indicators for several medical conditions and for mortality. CONCLUSIONS: These conventional tests are widely available and relatively inexpensive. While having limited sensitivity and specificity in detection of excessive drinking, they also provide valuable data on complications of drinking, comorbid conditions that may be affected by drinking and, in some cases, prognosis.
Authors: Sonja Kilo; Birgit Hofmann; Elisabeth Eckert; Thomas Göen; Hans Drexler Journal: Int Arch Occup Environ Health Date: 2016-07-09 Impact factor: 3.015
Authors: John B Whitfield; Steven Masson; Suthat Liangpunsakul; Jessica Hyman; Sebastian Mueller; Guruprasad Aithal; Florian Eyer; Dermot Gleeson; Andrew Thompson; Felix Stickel; Michael Soyka; Ann K Daly; Heather J Cordell; Tiebing Liang; Tatiana Foroud; Lawrence Lumeng; Munir Pirmohamed; Bertrand Nalpas; Camille Bence; Jean-Marc Jacquet; Alexandre Louvet; Romain Moirand; Pierre Nahon; Sylvie Naveau; Pascal Perney; Philippe Podevin; Paul S Haber; Helmut K Seitz; Christopher P Day; Philippe Mathurin; Timothy M Morgan; Devanshi Seth Journal: Alcohol Date: 2017-09-23 Impact factor: 2.405
Authors: R Louise Floyd; Mark Sobell; Mary M Velasquez; Karen Ingersoll; Mary Nettleman; Linda Sobell; Patricia Dolan Mullen; Sherry Ceperich; Kirk von Sternberg; Burt Bolton; Kenneth Johnson; Bradley Skarpness; Jyothi Nagaraja Journal: Am J Prev Med Date: 2007-01 Impact factor: 5.043
Authors: Jenny H D A van Beek; Marleen H M de Moor; Eco J C de Geus; Gitta H Lubke; Jacqueline M Vink; Gonneke Willemsen; Dorret I Boomsma Journal: Behav Genet Date: 2013-04-12 Impact factor: 2.805